GlaxoSmithKline traded at 1,780.40 this Wednesday May 25th, decreasing 1.60 or 0.09 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline lost 1.47 percent. Over the last 12 months, its price rose by 31.57 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,713.09 by the end of this quarter and at 1,587.31 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1,780.40
Daily Change
-0.09%
Yearly
31.57%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 151.98 2.86 1.92% 32.50%
Alcon AG 70.32 -0.18 -0.26% 13.53%
Almirall SA 10.43 0.08 0.77% -24.42%
Amgen 252.76 0.87 0.35% 5.96%
argenx SE 295.10 1.20 0.41% 31.33%
Artemis Alpha 300.00 -1.00 -0.33% -33.26%
AstraZeneca 10,554.00 -44.00 -0.42% 31.60%
Bayer 63.89 0.60 0.95% 16.23%
Biogen 202.08 -0.46 -0.23% -24.55%
Bristol-Myers Squibb 77.25 0.12 0.15% 16.81%
Fresenius Medical Care 56.74 0.80 1.43% -14.21%
Fresenius 31.93 0.28 0.88% -27.80%
Genmab 2,138.00 14.00 0.66% -12.12%
Gilead Sciences 64.99 0.64 0.99% -2.06%
Galapagos 51.26 -0.30 -0.58% -14.69%
GRIFOLS 19.75 -0.20 -1.00% -15.45%
GlaxoSmithKline 1,780.40 -1.60 -0.09% 31.57%
Hikma Pharmaceutical 1,675.00 -15.00 -0.89% -32.81%
Eli Lilly 307.02 1.06 0.35% 52.75%
Lonza Group 551.60 -3.40 -0.61% -4.07%
H Lundbeck A/S 162.50 0.15 0.09% -17.97%
Merck 176.15 1.05 0.60% 19.63%
Merck & Co 93.74 -0.91 -0.96% 21.37%
Novartis 88.13 0.45 0.51% 10.93%
Orion 37.99 0.11 0.29% 3.04%
Pfizer 53.72 0.31 0.58% 38.03%
Philips 23.17 -0.12 -0.49% -50.35%
Recordati 41.54 0.04 0.10% -9.58%
Regeneron Pharmaceuticals 690.42 4.40 0.64% 38.87%
Roche Holding 332.60 1.15 0.35% 6.50%
Sanofi 103.86 0.24 0.23% 17.14%
Smith & Nephew PLC 1,284.97 -6.53 -0.51% -17.63%
UCB 82.46 -0.50 -0.60% 5.50%

Indexes Price Day Year
GB100 7523 38.40 0.51% 7.06%

GlaxoSmithKline
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.